Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
10/24/2007 | CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy |
10/24/2007 | CN101057996A Rapamycins coating catheter |
10/24/2007 | CN101057921A Traditional Chinese medicine capsule for treating prostatic hyperplasia |
10/24/2007 | CN101057855A Medicinal composition containing epimedium active constituent and its application |
10/24/2007 | CN101057677A 新禧营养素增补剂 Sun Hey nutrient supplements |
10/24/2007 | CN101057671A Soup containing walnut and euryale ferox powder |
10/24/2007 | CN101057665A Stewed white pigeon with wolfberry fruit |
10/24/2007 | CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents |
10/24/2007 | CN100344646C Oligonucleotide-containing pharmacological compositions and their use |
10/24/2007 | CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
10/24/2007 | CN100344632C 稠合的呋喃化合物 Fused furan compound |
10/24/2007 | CN100344616C Compounds for the treatment of metabolic disorders |
10/24/2007 | CN100344319C Chinese medicine composition for treating urogenital system disease and its preparing method and use |
10/24/2007 | CN100344278C Lasofoxifene tablet and its coating |
10/23/2007 | US7285680 β-alanine derivatives and the use thereof |
10/23/2007 | US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments |
10/23/2007 | US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity |
10/23/2007 | US7285564 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects |
10/23/2007 | US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1) |
10/23/2007 | US7285549 Sulfamides and their use as endothelin receptor antagonists |
10/23/2007 | US7285382 Compositions and methods for treatment of cancer |
10/23/2007 | CA2221900C Use of trospium chloride and 2-component system for the same |
10/18/2007 | WO2007116428A2 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis |
10/18/2007 | WO2007115973A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet |
10/18/2007 | WO2007092721A3 Vitamin d analog: rak, methods and uses thereof |
10/18/2007 | WO2007092720A3 Vitamin d analog: nel, methods and uses thereof |
10/18/2007 | WO2007038658A3 Antibody-drug conjugates and methods of use |
10/18/2007 | US20070244172 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244171 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244141 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244047 Albumin fusion proteins |
10/18/2007 | CA2648281A1 Co-administration of adenosine a1 receptor antagonists and anticonvulsants |
10/18/2007 | CA2648172A1 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages |
10/17/2007 | EP1845104A1 Par-2 agonist |
10/17/2007 | EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor |
10/17/2007 | EP1845081A1 Amide compound |
10/17/2007 | EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases |
10/17/2007 | EP1844773A1 Percutaneous absorption preparation |
10/17/2007 | EP1843999A1 Process for preparing tolterodine tartrate |
10/17/2007 | EP1843772A1 Intravenous formulations of pde-5 inhibitors |
10/17/2007 | EP1843765A2 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
10/17/2007 | EP1843758A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
10/17/2007 | EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
10/17/2007 | EP1474395B1 Nicotinamide derivates useful as p38 inhibitors |
10/17/2007 | EP1372638A4 Functional role for cannabinoids in autonomic stability during sleep |
10/17/2007 | EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
10/17/2007 | EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
10/17/2007 | EP1141728B1 Kidney disease detection and treatment |
10/17/2007 | EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
10/17/2007 | EP0787122B9 Calcium receptor-active compounds |
10/17/2007 | CN101056638A Treatment of mastitis with enrofloxacin |
10/17/2007 | CN101056627A Therapeutic agent for interstitial cystitis |
10/17/2007 | CN101054414A Method of extracting and preparing deer DGF |
10/17/2007 | CN101054344A Lipoxin A4 analogs |
10/17/2007 | CN101053641A Baoyuan kidney-invigorating navel plaster |
10/17/2007 | CN101053636A Medicinal composition for treating prostate and its preparation method and application |
10/17/2007 | CN101053616A Medicine for treating uremia |
10/17/2007 | CN101053594A Traditional Chinese medicinal composition for treating lithiasis and its preparation method |
10/17/2007 | CN101053559A New application in medicine for compounds derived from phenyl acrylic acid |
10/17/2007 | CN101053438A Health care beverage |
10/17/2007 | CN101053421A Radish abalone soup |
10/17/2007 | CN101053420A Oyster yin-nourishing soup |
10/17/2007 | CN101053412A Pork liver blood-enriching soup |
10/17/2007 | CN101053411A Medlar shredded pork |
10/17/2007 | CN100343238C Quinazoline derivatives as antitumor agents |
10/17/2007 | CN100343227C Process for resolution of tamsulosin |
10/17/2007 | CN100342908C Pharmaceutical form of administration for peptides, method for its production and use |
10/17/2007 | CN100342888C Chinese medicine preparation for treating prostatic hyperplasia |
10/17/2007 | CN100342867C Kidney-nourishing yang-strengthening medicine |
10/16/2007 | US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
10/16/2007 | US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
10/16/2007 | US7282504 Kinase inhibitors |
10/16/2007 | US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide |
10/16/2007 | US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
10/16/2007 | US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening |
10/16/2007 | US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease |
10/16/2007 | CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
10/16/2007 | CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
10/11/2007 | WO2007115071A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
10/11/2007 | WO2007114534A1 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
10/11/2007 | WO2007113243A2 Use of pde 5 inhibitors for the treatment of overactive bladder |
10/11/2007 | WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
10/11/2007 | US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
10/11/2007 | US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine |
10/11/2007 | US20070238763 Urea derivatives as integrin a4 antagonists |
10/11/2007 | US20070238761 Use of pyridoxamine to treat and/or prevent disease processes |
10/11/2007 | US20070238759 Novel Polymorph V of Torasemide |
10/11/2007 | US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
10/11/2007 | US20070238693 Genetic modification of the lung as a portal for gene delivery |
10/11/2007 | CA2648033A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
10/10/2007 | EP1842918A1 Receptor nucleic acids and polypeptides |
10/10/2007 | EP1842543A1 Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist |
10/10/2007 | EP1841434A1 Combination therapy for treating heart disease |
10/10/2007 | EP1841316A2 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases |
10/10/2007 | EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
10/10/2007 | EP1381608B1 Cyclohexylphenyl vasopressin agonists |
10/10/2007 | EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist |
10/10/2007 | EP1347990B1 Peptides having inhibiting activity to nitric oxyde production |
10/10/2007 | EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
10/10/2007 | EP1232150B1 Urea derivatives as anti-inflammatory agents |